Drug profile · INN
dobutamine hydrochloride
DOBUTAMINE HYDROCHLORIDE
dobutamine hydrochloride (DOBUTAMINE HYDROCHLORIDE) is a beta-1 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — dobutamine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
dobutamine hydrochloride (DOBUTAMINE HYDROCHLORIDE) is a beta-1 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor agonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dobutamine hydrochloride?
dobutamine hydrochloride (DOBUTAMINE HYDROCHLORIDE) is a beta-1 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dobutamine hydrochloride?
DOBUTAMINE HYDROCHLORIDE is a marketed brand name for dobutamine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dobutamine hydrochloride?
dobutamine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.